August 25, 2016 / 4:42 PM / in a year

BUZZ-Mylan NV: To reduce EpiPen's cost

(Updates)

** Generic drug maker’s shares rise as much as 4.6 pct before paring its gains to trade up 0.5 pct at $43.39

** Mylan said it would reduce the out-of-pocket cost of its severe allergy treatment EpiPen through a discount program, a day after Democratic Presidential candidate Hillary Clinton joined lawmakers in criticizing the drug’s high price

** Clinton’s spokesman says “discounts for selected customers without lowering the overall price of EpiPens are insufficient”

** Co said it would reduce the patient cost of EpiPen through the use of a savings card, which will cover up to $300 of EpiPen 2-Pak

** Other specialty drugmakers such as Mallinckrodt and Valeant Pharmaceuticals rise, while pharmacy benefit managers CVS Health and Express Scripts slump

** While the PBMs are realizing some of the benefits from these price increases, much is being passed along to their clients in our view - Leerink analysts write

** Up to Wednesday’s close, Mylan had fallen 20.2 pct YTD and fell 9.2 pct after the price hike scrutiny for EpiPen

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below